Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

ion agreement. 

The reconciliation table is based in part on management's estimate of non-GAAP net income for the year ending December 31, 2013.  Actavis expects certain known GAAP charges for 2013, as presented in the schedule above.  Other GAAP charges that may be excluded from non-GAAP net income are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown.  These GAAP charges are dependent upon future events and valuations that have not yet been performed.

The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2013 to adjusted EBITDA:Table 7Actavis, Inc.Reconciliation Table - Forecasted Adjusted EBITDA(Unaudited; in millions)Forecast for Twelve Months
Ending December 31, 2013LowHighGAAP net income

$
440$
490Plus:Interest expense

215215Interest income

(1)(1)Provision for income taxes

185200Depreciation (includes accelerated depreciation)

195195Amortization

625630EBITDA

1,6591,729Adjusted for:Global supply chain initiative

66Acquisition and licensing charges

150150Non-cash impairment charges Non-recurring (gains) losses Share-based compensation

5555Adjusted EBITDA

$
,870$
,940The reconciliation table is based in part on management's estimate of adjusted EBITDA for the year ending December 31, 2013.  Actavis expects certain known GAAP charges for 2013, as presented in the schedule above.  Other GAAP charges that may be excluded from estimated EBITDA are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown.  These GAAP charges are dependent upon future events and valuations that have not yet been performed.

(Logo:

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ... that is developing new, patent-pending technologies poised to redefine how ... it will hold a business update teleconference and webcast for ... , 2013 at 4:30 PM ET. Fuse ... host the call and will be joined by ...
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... Amsterdam Molecular,Therapeutics (AMT) and Progenika Biopharma announced today ... agreement for,LPLchip(TM), a diagnostic tool to rapidly diagnose patients ... developed Glybera(R) as,a gene therapy for patients with this ... this year AMT announced new clinical data showing that ...
... , CHAPEL HILL, N.C., Oct. 29 Cempra Pharmaceuticals ... CEM-101, at the Infectious Diseases Society of America, 47th ... Philadelphia. , Susceptibility of CEM-101 and more than 25 ... pneumoniae strains collected in 2008 from medical centers ...
Cached Medicine Technology:AMT Starts Development LPLChip(TM) With Progenika 2AMT Starts Development LPLChip(TM) With Progenika 3Data Presented on Cempra Pharmaceutical's CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates 2
(Date:5/17/2013)... found to have an abnormality on routine mammogram or ... up having an old-fashioned surgical biopsy to find out ... expert panels have recommended that the first course of ... be minimally invasive biopsy. , Minimally invasive biopsies are ... either a fine needle or preferably a "core tissue ...
(Date:5/17/2013)... when the U.S. health system is facing both an ... shortage of primary care physicians, one broadly recommended strategy ... of nurse practitioners. In 2010 an Institute of Medicine ... be able to practice to the full extent of ... be able to admit patients to hospitals and hospices, ...
(Date:5/17/2013)... Arrowhead, CA (PRWEB) May 17, 2013 ... extra health complications, but for diabetics, treatment is more ... involves additional medical care to monitor blood sugar levels ... addicted diabetic properly, a drug rehab for diabetics ... unique dietary and nutritional needs of the diabetic, and ...
(Date:5/17/2013)... "screen time" and sleep on mood, memory and ... at the 2013 Intel International Science and Engineering ... school students. The awards are coordinated by the ... the National Institutes of Health, and Friends of ... Intel ISEF Addiction Science Awards were presented at ...
(Date:5/17/2013)... May 17 (HealthDay News) -- Too few obstetrics-gynecology residents ... which could lead to care issues for the rapidly ... finds. Researchers surveyed 510 ob/gyn residents and found ... training in menopause medicine, even though seven in 10 ... 60 percent of fourth-year residents -- those soon to ...
Breaking Medicine News(10 mins):Health News:More than one-third of Texas women still receive unnecessary breast biopsy surgery 2Health News:Study finds disagreement on the role of primary care nurse practitioners 2Health News:Study finds disagreement on the role of primary care nurse practitioners 3Health News:Study finds disagreement on the role of primary care nurse practitioners 4Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 2Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 4Health News:Is Menopause Overlooked in U.S. Medical Schools? 2
... statins to patients with diastolic heart failure increases// the ... drugs. ,William C. Little and his research ... with diastolic heart failure (DHF) treated with statins has ... diastolic heart failure patients published in the Journal Circulation: ...
... July 23 Prime Minister Manmohan Singh today said ... measures and coercion of any control to achieve ... first meeting of the reconstituted National Commission on ... strategy focusing on the welfare of women and ...
... Pre-eclampsia is a disease that causes high blood pressure in ... death of mother and infant in the world. Now a ... women who are likely to develop the problem. ... "We're really excited about this finding," said Clifford Librach, a ...
... can severely affect brain functions like learning and impulsive behavior.// ... latest issue of New Scientist, said that it would help ... ., ,Neuroscientists Yuriori Goto and his team at the ... stimulated the two different regions of the brain in a ...
... who are training for marathon running events may be ... from low levels of sodium in the body. The ... drink excess amounts of fluids during exercises. ,Awareness ... professionals need reliable information on the causes, recognition, prevention, ...
... Buffalo, has found that Post-menopausal// women has an increased chance ... Journal of Periodontology, which was conducted in 106 Post-menopausal women ... 57.5% of the women in the study lost at least ... loss in Post-menopausal women, as studies has proved that loss ...
Cached Medicine News:Health News:Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients 2Health News:Prime Minister Manmohan Against Incentive-Based Population Control 2Health News:Prime Minister Manmohan Against Incentive-Based Population Control 3Health News:Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child 2Health News:Regular Use Of Cocaine Can Impair Brain Functions 2Health News:Athletes Warned Of Exercise-Associated Hyponatremia 2Health News:Post-Menopausal Status May Cause Tooth Decay 2